SCHEMBL381880

SCHEMBL381880

CCS(=O)(=O)NCC(c1cccc(C(F)(F)F)c1)N(C(=O)O)C(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
ALDH1A1 P00352 2/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP1A2 P05177 1/20 0.42
POLB P06746 1/20 0.42
NPSR1 Q6W5P4 3/20 0.39
MAPT P10636 3/20 0.39
HTT P42858 3/20 0.39
BCHE P06276 2/20 0.38
LMNA P02545 2/20 0.38
GAA P10253 1/20 0.38
XBP1 P17861 1/20 0.38
PAX8 Q06710 1/20 0.38
CES2 O00748 1/20 0.38
TP53 P04637 1/20 0.38
ALOX15 P16050 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL380987 0.90 ALDH1A1 (0.40) SMN1; SMN2MEN1KMT2AALDH1A1CYP3A4
SCHEMBL381695 0.83 OPRM1 (0.43) SMN1; SMN2MEN1KMT2AALDH1A1CYP3A4
SCHEMBL19244872 0.83 OPRM1 (0.48) SMN1; SMN2MEN1KMT2AALDH1A1CYP3A4
SCHEMBL381593 0.82 BCHE (0.41) SMN1; SMN2MEN1KMT2AALDH1A1CYP3A4
SCHEMBL19244815 0.82 ACP3 (0.40) SMN1; SMN2MEN1KMT2AALDH1A1CYP3A4
SCHEMBL15170368 0.81 ACP3 (0.47) SMN1; SMN2MEN1KMT2AALDH1A1CYP3A4
SCHEMBL381185 0.81 ACP3 (0.47) SMN1; SMN2MEN1KMT2AALDH1A1CYP3A4
SCHEMBL414657 0.80 ACP3 (0.43) SMN1; SMN2MEN1KMT2AALDH1A1CYP3A4
SCHEMBL16674214 0.80 PNMT (0.52) SMN1; SMN2MEN1KMT2AALDH1A1CYP3A4
SCHEMBL19244821 0.80 ACP3 (0.39) SMN1; SMN2MEN1KMT2AALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2408751-B1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof BAYER IP GMBH (DE) 2017-08-23 EP disclosed
EP-2408751-A1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof Bayer Pharma Aktiengesellschaft (DE) 2012-01-25 EP disclosed
WO-2010105770-A1 SUBSTITUTED 2-ACETAMIDO-5-ARYL-1,2,4-TRIAZOLONES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-09-23 WO disclosed